At present, the lack of large-scale, confirmatory clinical trials specifically targeting MC4R deficiency is largely due to significant scientific and clinical heterogeneity, which has made conducting such trials logistically challenging and commercially less appealing compared to pursuing broader or more clearly defined patient populations
This type of medication has been associated with a reduced risk of certain substance use disorders , and can potentially reduce inflammation in the brain (which is thought to factor into certain mood disorders)
The SELECT trial's cardiovascular benefit data (20% MACE reduction) has been particularly influential in changing payer attitudes, because preventing heart attacks and strokes saves money long-term
The behaviors you establish while on the medication form the foundation for whatever comes next
17 However, the FTC has recently challenged these listings as improper because the patents often do not recite the active ingredient
Kitzman DW, Lam CSP (2017) Obese heart failure with preserved ejection fraction phenotype: from pariah to central player
/product/51/4175523/1.jpg?8625)
